Skip to main content
Sanofi (BIT:1SAN)
Italy flag Italy · Delayed Price · Currency is EUR
97.97
+1.40 (1.45%)
At close: May 2, 2025, 5:30 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Total Vaccine
Log In
Log In
Log In
Log In
Total Vaccine Growth
Log In
Log In
Log In
Log In
Total Pharmaceutical
Log In
Log In
Log In
Log In
Total Pharmaceutical Growth
Log In
Log In
Log In
Log In
Opella Consumer Healthcare
Log In
Log In
Log In
Log In
Opella Consumer Healthcare Growth
Log In
Log In
Log In
Log In
Dupixent
Log In
Log In
Log In
Log In
Dupixent Growth
Log In
Log In
Log In
Log In
Total Neurology & Immunology
Log In
Log In
Log In
Log In
Total Neurology & Immunology Growth
Log In
Log In
Log In
Log In
Total Rare Diseases
Log In
Log In
Log In
Log In
Total Rare Diseases Growth
Log In
Log In
Log In
Log In
Total Oncology
Log In
Log In
Log In
Log In
Total Oncology Growth
Log In
Log In
Log In
Log In
Total Rare Blood Disorders
Log In
Log In
Log In
Log In
Total Rare Blood Disorders Growth
Log In
Log In
Log In
Log In
Total Core Assets
Log In
Log In
Log In
Log In
Total Core Assets Growth
Log In
Log In
Log In
Log In
Total Non-Core Assets
Log In
Log In
Log In
Log In
Total Non-Core Assets Growth
Log In
Log In
Log In
Log In
Industrial
Log In
Log In
Log In
Log In
Industrial Growth
Log In
Log In
Log In
Log In
BioPharma
Log In
Log In
Log In
Log In
BioPharma Growth
Log In
Log In
Log In
Log In
Specialty Care
Log In
Log In
Log In
Log In
Pharma
Log In
Log In
Log In
Log In

EBIT by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceutical Operating Income
Log In
Log In
Log In
Log In
Pharmaceutical Operating Income Growth
Log In
Log In
Log In
Log In
Vaccine Operating Income
Log In
Log In
Log In
Log In
Vaccine Operating Income Growth
Log In
Log In
Log In
Log In
Other Operating Income
Log In
Log In
Log In
Log In
Other Operating Income Growth
Log In
Log In
Log In
Log In
Consumer Healthcare Operating Income
Log In
Log In
Log In
Log In
Consumer Healthcare Operating Income Growth
Log In
Log In
Log In
Log In
Biopharma Operating Income
Log In
Log In
Log In
Log In
Biopharma Operating Income Growth
Log In
Log In
Log In
Log In
Opella Consumer Healthcare (Post-2022 Reporting) Operating Income
Log In
Log In
Log In
Log In
Other (Post-2022 Reporting) Operating Income
Log In
Log In
Log In
Log In
Other (Post-2022 Reporting) Operating Income Growth
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
United States
Log In
Log In
Log In
Log In
United States Growth
Log In
Log In
Log In
Log In
Europe
Log In
Log In
Log In
Log In
Europe Growth
Log In
Log In
Log In
Log In
Rest of World
Log In
Log In
Log In
Log In
Rest of World Growth
Log In
Log In
Log In
Log In